Eric H. Bjerkholt
A senior executive with more than two decades of experience in the healthcare and life science sectors, Mr. Bjerkholt is Executive Vice President, Corporate Development and Finance and Chief Financial Officer of Sunesis Pharmaceuticals, Inc., a biopharmaceutical company developing oncology therapeutics, having joined Sunesis in 2004 as Senior Vice President and Chief Financial Officer. From 2002 to 2004, he was Senior Vice President and Chief Financial Officer at IntraBiotics Pharmaceuticals, Inc., which was a biopharmaceutical company that was acquired by Ardea Biosciences, Inc. in December 2006. Mr. Bjerkholt was a co-founder of LifeSpring Nutrition, Inc., a nutraceutical company, and from 1999 to 2002 served at various times as its Chief Executive Officer, President, and Chief Financial Officer. He also served as a vice president in the healthcare banking group at J.P. Morgan & Co. Incorporated from 1990 to 1997. He holds a Cand. Oecon degree in Economics from the University of Oslo and an M.B.A. from Harvard Business School.